Search results for "Protein"

showing 10 items of 21431 documents

LARP7 variants and further delineation of the Alazami syndrome phenotypic spectrum among primordial dwarfisms: 2 sisters.

2019

Abstract Alazami syndrome (AS) (MIM# 615071 ) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7. To date, 15 patients with AS have been reported. Here we describe two consanguineous Algerian sisters with Alazami PD due to LARP7 homozygous pathogenic variants detected by whole exome sequencing. By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full li…

medicine.medical_specialtyHeart malformation[SDV]Life Sciences [q-bio]Dwarfism03 medical and health sciencesLoss of Function MutationIntellectual DisabilityIntellectual disabilityGeneticsmedicineHumansChildGenetics (clinical)Exome sequencingLoss function030304 developmental biology0303 health sciencesbusiness.industrySiblings030305 genetics & heredityGeneral MedicineSyndromemedicine.diseaseDermatologyPhenotype[SDV] Life Sciences [q-bio]PhenotypeRibonucleoproteinsEtiologyMicrocephalyFemalePrimordial dwarfismbusinessMild microcephalyEuropean journal of medical genetics
researchProduct

A human hepatocellular in vitro model to investigate steatosis

2006

The present study was designed to define an experimental model of hepatocellular steatosis with a fat overaccumulation profile in which the metabolic and cytotoxic/apoptotic effects could be separated. This was accomplished by defining the experimental conditions of lipid exposure that lead to significant intracellular fat accumulation in the absence of overt cytotoxicity, therefore allowing to differentiate between cytotoxic and apoptotic effects. Palmitic (C16:0) and oleic (Cl 8: 1) acids are the most abundant fatty acids (FFAs) in liver triglycerides in both normal subjects and patients with nonalcoholic fatty liver disease (NAFLD). Therefore, human hepatocytes and HepG2 cells were incub…

medicine.medical_specialtyHepG2Carcinoma HepatocellularCell SurvivalPalmitic AcidApoptosisBiologyFatty Acids NonesterifiedIn Vitro TechniquesToxicologyfatty acidscellular steatosisPalmitic acidchemistry.chemical_compoundInternal medicineCell Line TumorNonalcoholic fatty liver diseasemedicineHumansCytotoxicityDose-Response Relationship DrugapoptosisGeneral Medicinemedicine.diseaseFatty LiverDose–response relationshipmedicine.anatomical_structureEndocrinologychemistryBiochemistryApoptosisNeutral RedHepatocyteHepatocyteslipids (amino acids peptides and proteins)hepatocytesSteatosisIntracellularOleic Acid
researchProduct

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

2005

Background/Aims: Prediction of sustained virological response (SVR) during treatment would allow clinicians to identify patients most likely to benefit from therapy. Methods: Retrospective analysis of data from 1121 adults with chronic hepatitis C treated for 48 weeks with peginterferon alfa-2a (40 KD) 180 mu g/week plus placebo or ribavirin (1000/1200 mg/day), or interferon alfa-2b 3 MIU three times/week plus ribavirin in a randomized, multinational, study. Results: 67% of patients treated with peginterferon alfa-2a (40 KD)/ribavirin with early virological responses (HCV RNA negative or >= 2 log(10) decrease) at week 12 had SVRs at week 72 (HCV RNA 80 % of the planned ribavirin dose. Concl…

medicine.medical_specialtyHepatitis B virusviral hepatitisAlpha interferonPeginterferon-alfaInterferon alpha-2medicine.disease_causeGastroenterologyAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundpredictabilityInternal medicineRibavirinmedicinechronic hepatitis CHumansProbabilityRetrospective StudiesHepatitis B viruspeginterferon alfa-2a (40 KD)treatmentHepatologyDose-Response Relationship Drugbusiness.industryRibavirinvirus diseasesInterferon-alphaHepatitis CHepatitis C ChronicViral Loadmedicine.diseasedigestive system diseasesRecombinant ProteinsTreatment OutcomechemistryImmunologyRNA ViralDrug Therapy Combinationsustained virological responseViral hepatitisbusinessViral loadPeginterferon alfa-2amedicine.drugJournal of hepatology
researchProduct

Patient-to-patient transmission of hepatitis C virus (HCV) during colonoscopy diagnosis

2010

Abstract Background No recognized risk factors can be identified in 10-40% of hepatitis C virus (HCV)-infected patients suggesting that the modes of transmission involved could be underestimated or unidentified. Invasive diagnostic procedures, such as endoscopy, have been considered as a potential HCV transmission route; although the actual extent of transmission in endoscopy procedures remains controversial. Most reported HCV outbreaks related to nosocomial acquisition have been attributed to unsafe injection practices and use of multi-dose vials. Only a few cases of likely patient-to-patient HCV transmission via a contaminated colonoscope have been reported to date. Nosocomial HCV infecti…

medicine.medical_specialtyHepatitis C virusMolecular Sequence DataColonoscopyHepacivirusViral Nonstructural Proteinsmedicine.disease_causelcsh:Infectious and parasitic diseaseschemistry.chemical_compoundVirologyEpidemiologyDisease Transmission InfectiousmedicineHumanslcsh:RC109-216NS5BRetrospective StudiesCross InfectionMolecular Epidemiologymedicine.diagnostic_testbusiness.industryTransmission (medicine)ResearchOutbreakRetrospective cohort studyColonoscopySequence Analysis DNAHepatitis Cmedicine.diseaseHepatitis CVirologyInfectious DiseaseschemistryRNA ViralbusinessVirology Journal
researchProduct

Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation

2014

Background & Aims Recurrence of hepatitis C virus (HCV) infection after orthotopical liver transplantation (OLT) is common and associated with reduced graft and patient survival. The protease inhibitor telaprevir may enhance virological response rates in patients after OLT in combination with pegylated interferon-alfa and ribavirin. Pharmacokinetic studies have shown significant drug–drug interactions between telaprevir and immunosuppression (IS), but telaprevir pharmacokinetics in OLT patients with IS are unknown. Aim of the present study was to analyse telaprevir plasma concentrations in patients with HCV genotype 1 infection after OLT in comparison to patients without OLT and IS. Methods…

medicine.medical_specialtyHepatitis C virusmedicine.medical_treatmentPharmacologyLiver transplantationmedicine.disease_causeAntiviral AgentsGastroenterologyStatistics NonparametricTacrolimusPolyethylene GlycolsTelaprevirchemistry.chemical_compoundRecurrenceTandem Mass SpectrometryInternal medicineRibavirinmedicineHumansProspective StudiesImmunosuppression TherapyHepatologybusiness.industryRibavirinInterferon-alphaHepatitis Cmedicine.diseaseHepatitis CRecombinant ProteinsTacrolimusLiver TransplantationTransplantationsurgical procedures operativechemistryDrug Therapy CombinationDrug MonitoringbusinessViral hepatitisOligopeptidesChromatography Liquidmedicine.drugLiver International
researchProduct

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS

2021

Background & Aims The histopathological subtypes of hepatocellular carcinoma (HCC) are associated with distinct clinical features and prognoses. This study aims to report Liver Imaging Reporting and Data System (LI-RADS)-defined imaging features of different HCC subtypes in a cohort of resected tumours and to assess the influence of HCC subtypes on computed tomography (CT)/magnetic resonance imaging (MRI) LI-RADS categorisation in the subgroup of high-risk patients. Methods This retrospective institutional review board-approved study included patients with resected HCCs and available histopathological classification. Three radiologists independently reviewed preoperative CT and MRI exams. T…

medicine.medical_specialtyHepatocellular carcinomaALT alanine transaminaseComputed tomographyRC799-869AST aspartate aminotransferaseOS overall survivalHistopathological subtypeMagnetic resonance imagingNOS-HCC not otherwise specified hepatocellular carcinomaInternal MedicinemedicineImmunology and AllergyIn patientComputed tomographyLI-RADS Liver Imaging Reporting and Data SystemLiver imagingHepatologymedicine.diagnostic_testbiologyUS ultrasoundbusiness.industryNot Otherwise SpecifiedGastroenterologyTIV tumour-in-veinMagnetic resonance imagingHBP hepatobiliary phaseDiseases of the digestive system. Gastroenterologymedicine.diseasedigestive system diseasesHistopathological subtypesCT computed tomographyRFS recurrence-free survivalAlanine transaminaseHepatocellular carcinomaSH-HCC steatohepatitic hepatocellular carcinomaCohortMTM-HCC macrotrabecular-massive hepatocellular carcinomabiology.proteinLI-RADSRadiologyAPHE arterial phase hyperenhancementbusinessHCC hepatocellular carcinomaMRI magnetic resonance imagingResearch ArticleJHEP Reports
researchProduct

Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study

2004

Summary Background : In patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels, liver fibrosis has been reported in 0–22% of cases and advanced liver disease in 5–10% of cases. Aim : To determine whether patients with persistently normal alanine aminotransferase levels clear infection after anti-viral therapy at equal or different rates from infected patients with raised alanine aminotransferase levels. Methods : Thirty-five hepatitis C virus RNA-positive patients with fibrosis at liver histology (Group 1) were matched for genotype, sex, age and histology with patients with raised alanine aminotransferase levels (Group 2). Both groups were …

medicine.medical_specialtyHepatologyCombination therapybiologybusiness.industryRibavirinHepatitis C virusGastroenterologyOdds ratiomedicine.disease_causemedicine.diseaseVirologyGastroenterologyConfidence intervalchemistry.chemical_compoundLiver diseaseAlanine transaminasechemistryFibrosisInternal medicinebiology.proteinmedicinePharmacology (medical)businessAlimentary Pharmacology & Therapeutics
researchProduct

Prostanoid release of cultured liver sinusoidal endothelial cells in response to endotoxin and tumor necrosis factor

1990

Abstract Vascular endothelial cells release prostanoids, especially prostacyclin, when properly stimulated. In addition to short acting stimuli like thrombin and histamine an increased prostanoid release occurs in the presence of endotoxin, interleukin 1 or tumor necrosis factor (TNF). The response of sinusoidal endothelial liver cells to such stimuli — probably important in hepatic inflammatory disease — is unknown. Sinusoidal endothelial liver cells from the guinea pig were isolated by centrifugal elutriation and investigated as confluent monolayers. Their prostanoid release in response to endotoxin and human recombinant TNF was determined by radioimmunoassays and compared to that obtaine…

medicine.medical_specialtyHepatologyInterleukinProstanoidProstacyclinBiologyUmbilical veinEndothelial stem cellchemistry.chemical_compoundEndocrinologychemistryCell cultureInternal medicinecardiovascular systemmedicinelipids (amino acids peptides and proteins)Tumor necrosis factor alphaHistaminemedicine.drugJournal of Hepatology
researchProduct

Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis

1988

Although the presence of anti-mitochondrial antibodies is the main characteristic of primary biliary cirrhosis (PBC), other autoantibodies have been described in this disease. This study employs immunoblot methods to test whether the sera of PBC patients also contain antibodies directed against nicotinic acetylcholine receptors (AChR). We show that the majority of patients' sera indeed react with AChR just as sera of myasthenic patients do. In contrast, however, these anti-AChR antibodies do not lead to significant clinical symptoms of myasthenia. In all cases studied, PBC sera recognized a protein with the molecular weight of the alpha-chain of acetylcholine receptor (40 kDa). In addition,…

medicine.medical_specialtyHepatologyLiver Cirrhosis BiliaryAutoantibodyBiologymedicine.diseaseImmunohistochemistryPrimary biliary cirrhosisNicotinic agonistEndocrinologyAntigenInternal medicinemedicinebiology.proteinHumansImmunohistochemistryElectrophoresis Polyacrylamide GelReceptors CholinergicIsoelectric PointAntibodyReceptorImmunosorbent TechniquesAutoantibodiesAcetylcholine receptorJournal of Hepatology
researchProduct

Barbiturate jaundice

1969

Summary A case of barbital-induced jaundice is described. The patient, a 31-year-old woman, developed generalized skin eruption, mucosal lesions, and fever 2 hr after the ingestion of 2 tablets of a barbital-containing drug (Veramon). She then developed a deep cholestatic jaundice which lasted more than 7 months. During the remission of jaundice, a rechallenge with phenobarbital caused a recurrence of fever and skin eruption, with exacerbation of jaundice.

medicine.medical_specialtyHepatologybiologyExacerbationmedicine.diagnostic_testbusiness.industrymedicine.drug_classGastroenterologyJaundiceBarbitalGastroenterologyAlanine transaminaseBarbiturateAnesthesiaInternal medicinebiology.proteinMedicineIngestionPhenobarbitalmedicine.symptombusinessLiver function testsmedicine.drugGastroenterology
researchProduct